Lynn has handled complex patent and other intellectual property litigation in the life sciences, software, internet and hardware industries for over 30 years representing cutting-edge technology companies, universities and their highly innovative inventors in their most important suits. This has included establishing the validity of biotech-pioneer Cetus' patents on its Nobel Prize-winning polymerase chain reaction invention against DuPont, enforcing Amazon.com's 1-Click® patent against its then-arch rival Barnesandnoble.com and assisting the University of California in protecting some of its most important inventions, including CRISPR/Cas9 and fluorescent in situ hybridization. Lynn also repeatedly has defeated suits against his clients by non-practicing entities and others through jury verdicts, summary judgments and other favorable resolutions finding the asserted patents invalid or not infringed.